[{"NetIncomeLoss_3_Q3_USD":-47809000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":-14287000.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":71300000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":48000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":108692000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":64184000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":354000.0,"LeaseIncentiveReceivable_0_Q3_USD":6884000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":-4767000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":71300000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":50320000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q3_USD":101240000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":50929575.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":46289103.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":19.34,"ProvisionForDoubtfulAccounts_3_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":4401000.0,"OperatingLeaseLiability_0_Q3_USD":28720000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":13000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":6200000.0,"ConvertibleDebtNoncurrent_0_Q3_USD":212651000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":5139000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":16613000.0,"InventoryValuationReserves_0_Q3_USD":3800000.0,"AccruedSalariesCurrent_0_Q3_USD":13393000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":16911846000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":16849452000.0,"CostMethodInvestments_0_Q3_USD":15000000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":1189000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":31951000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":100061000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":143003000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-446000.0,"OperatingLeaseExpense_1_Q3_USD":700000.0,"OperatingLeaseExpense_3_Q3_USD":500000.0,"AssetsCurrent_0_Q3_USD":497682000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":4054000.0,"Liabilities_0_Q3_USD":390807000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":765307000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":27922000.0,"CommonStockValue_0_Q3_USD":5000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":23000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-18888000.0,"AccountsReceivableNetCurrent_0_Q3_USD":15025000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":553000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":788000.0,"ProceedsFromStockPlans_3_Q3_USD":1098000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":57001000.0,"AssetsFairValueDisclosure_0_Q3_USD":456267000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":250000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":60000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":223300000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":105320000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":13000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":46734000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":32349000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-480000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q3_USD":0.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_3_Q3_USD":1345000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_1_Q3_USD":914000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":200481000.0,"OtherAssetsNoncurrent_0_Q3_USD":33689000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":6023000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":16482000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-23593000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-48179000.0,"IncreaseDecreaseInInventories_3_Q3_USD":3813000.0,"NumberOfBusinessesAcquired_3_Q3_business":2.0,"CostsAndExpenses_1_Q3_USD":70574000.0,"CostsAndExpenses_3_Q3_USD":204950000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":-10268000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_3_Q3_USD":6886000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q3_USD":13000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":102674000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-117000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":17946000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-10213000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":6020000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":250000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-479000.0,"ForeignCurrencyTransactionGainLossRealized_3_Q3_USD":-620000.0,"InterestIncomeExpenseNet_1_Q3_USD":1123000.0,"InterestIncomeExpenseNet_3_Q3_USD":4414000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_1_Q3_USD":-566000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_3_Q3_USD":-622000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-22526000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-66697000.0,"Goodwill_0_Q3_USD":936000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-28873000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":1144000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-3195000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":138045000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-464253000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":5400000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":7789000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":18296000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-530000.0,"CommonStockSharesOutstanding_0_Q3_shares":51023187.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":2858000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2412000.0,"LiabilitiesCurrent_0_Q3_USD":75426000.0,"NetIncomeLoss_1_Q3_USD":-22549000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":5696000.0,"ImpairmentOfRetainedInterest_1_Q3_USD":0.0,"ImpairmentOfRetainedInterest_3_Q3_USD":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":101240000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":154217000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":261000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":1748000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":13039000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":20181000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1345000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5516000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":200481000.0,"NonoperatingIncomeExpense_1_Q3_USD":-3091000.0,"NonoperatingIncomeExpense_3_Q3_USD":-9085000.0,"AccountsPayableCurrent_0_Q3_USD":9431000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":254655000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":93387000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2926000.0,"StockholdersEquity_0_Q3_USD":301413000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":51139000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":147338000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":6386000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":11130000.0,"ConvertibleDebtFairValueDisclosures_0_Q3_USD":230900000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OperatingIncomeLoss_3_Q3_USD":-57612000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":108692000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":26307000.0,"ShareBasedCompensation_3_Q3_USD":16612000.0,"Assets_0_Q3_USD":692220000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":255786000.0,"CommonStockSharesIssued_0_Q3_shares":51023187.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":223152000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q3_USD":-564000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OperatingIncomeLoss_1_Q3_USD":-19435000.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q3_USD":254655000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":198785000.0,"OtherLiabilitiesCurrent_0_Q3_USD":6775000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":40330000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.44,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.03,"OperatingLeaseLiabilityCurrent_0_Q3_USD":798000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q3_USD":0.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q3_USD":0.0,"ImpairmentOfIntangibleAssetsFinitelived_3_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":5398000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":17262000.0,"PreferredStockSharesAuthorized_0_Q3_shares":20000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":692220000.0,"PreferredStockValue_0_Q3_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":259537000.0,"IncomeTaxReceivable_0_Q3_USD":13615000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":12220000.0,"InventoryNet_0_Q3_USD":7259000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":603000.0,"Ticker":"TVTX","CIK":"1438533","name":"RETROPHIN, INC.","OfficialName":"Travere Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"1905907401.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]